BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Genetown

  Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) With an Exercise Price of $14.78

  Akebia granted nine newly-hired employees options to purchase an aggregate of 53,550 shares of Akebia’s common stock on January 31, 2018, as inducements material to each such employee’s entering into employment with Akebia.

  February 2, 2018

   · 

  1 min read
• Business

  Titan Announces Amendment to Horizon Loan Agreement

  Pursuant to this amendment, Titan will prepay $3M of the outstanding $7M principle amount, with an additional $1M prepayment due on the earlier of.

  February 2, 2018

   · 

  3 min read
• BioMidwest

  Respicardia Announces First U.S. Commercial Case With the remedē System

  The first case coincides with the naming of seasoned medical device executive, Peter Sommerness, as CEO of Respicardia and leader of the remede System U.S. launch.

  February 2, 2018

   · 

  3 min read
• Pharm Country

  Acorda Fourth Quarter/Year End 2017 Update

  Acorda will host a conference call and webcast to report its fourth quarter 2017 financial results and pipeline updates on Thursday, February 15 at 8:30 a.m. ET.

  February 2, 2018

   · 

  3 min read
• Deals

  Celgene Corporation Commences Tender Offer for Juno Therapeutics, Inc.

  The tender offer is being made in connection with the Agreement and Plan of Merger, dated January 21, 2018, by and among Celgene, Blue Magpie Corporation and Juno.

  February 2, 2018

   · 

  5 min read
• Novarum Webinar to Mythbust Smartphone Diagnostic Readers

  The potential of mobile phones to revolutionise point of care testing will be explored during a webinar hosted by leading smartphone diagnostics specialist Novarum DX.

  February 2, 2018

   · 

  1 min read
• Drug Development

  miRagen Therapeutics Presents New Data from Phase I Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum

  The data will be presented today, February 2, 2018, at the 10th Annual T-cell Lymphoma Forum in La Jolla, California.

  February 2, 2018

   · 

  9 min read
• Pharm Country

  Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe

  Percutaneous Hepatic Perfusion Therapy with Melphalan/HDS was developed by Delcath Systems as a targeted, whole organ therapy for the liver.

  February 2, 2018

   · 

  4 min read
• Business

  Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018

  The Company will host a conference call to discuss the financial results.

  February 2, 2018

   · 

  1 min read
• Kane Biotech Provides Additional Information Regarding Engagement of Investor Relations Counsel

  The following disclosure supplements the information contained in the Corporation’s press release from earlier today.

  February 2, 2018

   · 

  1 min read